NCT06770634 Investigation of Central Sensitization and Associated Factors in Patients With Lipedema
| NCT ID | NCT06770634 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey |
| Condition | Lipedema |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-12-06 |
| Primary Completion | 2025-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-12-06 with a primary completion date of 2025-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the presence of central sensitization and its associated parameters in patients with lipedema. Lipedema is a chronic and hereditary condition that primarily affects the lower extremities in women and is often associated with hormonal changes. Symptoms such as pain, swelling, and tenderness are common in lipedema, and these symptoms may be related to central sensitization. Additionally, the ultrasonographic findings and pain sensitivity in lipedema will be compared with those of healthy individuals. This study seeks to contribute to the diagnosis and treatment process of lipedema.
Eligibility Criteria
Inclusion Criteria: 1. Lipedema; Diagnosis of lipedema Aged between 18 and 65 years Literate Willing to participate in the study 2. control group; Being completely healthy (no internal/metabolic issues such as diabetes, obesity, or hypothyroidism, and no diagnosis of lipedema) BMI ≤ 30 Aged between 18 and 65 years Literate Willing to participate in the study Exclusion Criteria: 1. Lipedema group; Under 18 or over 65 years of age Presence of concurrent lymphedema, chronic venous insufficiency, deep vein thrombosis, polyneuropathy, or fibromyalgia Illiterate Not willing to participate in the study 2. Control group; Under 18 or over 65 years of age Presence of concurrent lymphedema, chronic venous insufficiency, deep vein thrombosis, polyneuropathy, fibromyalgia, systemic rheumatic diseases, active cancer, infections, or pregnancy Illiterate Not willing to participate in the study
Contact & Investigator
Emre Ata, Assoc.Prof
STUDY CHAIR
Sultan Abdülhamid Han Research and Training Hospital
Frequently Asked Questions
Who can join the NCT06770634 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Lipedema. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06770634 currently recruiting?
Yes, NCT06770634 is actively recruiting participants. Contact the research team at drzeynepcandan@gmail.com for enrollment information.
Where is the NCT06770634 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06770634 clinical trial?
NCT06770634 is sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey. The principal investigator is Emre Ata, Assoc.Prof at Sultan Abdülhamid Han Research and Training Hospital. The trial plans to enroll 50 participants.